Abeona Therapeutics® Announces Participation in Upcoming Investor Conferences
Abeona Therapeutics Inc., a commercial-stage biopharmaceutical company focused on cell and gene therapies, announced management participation in the 2026 Jefferies Global Healthcare Conference and Goldman Sachs 47th Annual Global Healthcare Conference. The company will discuss its commercial product ZEVASKYN and pipeline including ABO-701, advancin…